Skip to main content

ETF Objective

The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.

Stock Chart

as of 4:00 PM ET 05/19/2022

Performance

  • 1 Week
  • +4.70%
  • 1 Month
  • -9.86%
  • 3 Months
  • -5.46%
  • 1 Yr Return
  • -18.35%
  • 5 Yr Return
  • +23.32%

Sector Breakdown

Health Care 94.93%
Technology 4.95%

Geographic Exposure

United States 84.47%
Germany 4.76%
China 3.65%
Ireland 3.23%
Netherlands 2.70%
Switzerland 1.19%

Top 10 Holdings

Symbol Company Name % Of Assets
AMGN Amgen Inc ORD 13.00%
MRNA Moderna Inc ORD 7.62%
VRTX Vertex Pharmaceuticals Inc ORD 6.76%
GILD Gilead Sciences Inc ORD 6.60%
REGN Regeneron Pharmaceuticals Inc ORD 6.60%
ILMN Illumina Inc ORD 5.22%
IQV IQVIA Holdings Inc ORD 4.95%
BNTX BioNTech SE DR 4.76%
BIIB Biogen Inc ORD 4.40%
TECH Bio-Techne Corp ORD 4.24%

ETF Overview

Sponsor Van Eck
iNav Ticker BJW9
Inception Date 12/20/2011
Name VanEck:Biotech
CUSIP 92189F726
Prospectus Date 02/01/2022

ETF Characteristics

Market Capitalization 51.90 B
Total Net Assets 439.00
Management Fee 0.32%
Administration Fee 0.00%
Asset Class Equity
Sub Asset Class Health/Biotechnology Funds
Number Of Holdings 26
Expense Ratio 0.35
Dividend n/a
Dividend Frequency Annually

Recommended for You